 |
|
Dexmedetomidine and propofol sedation requirements in an autistic rat model
Soha A. Elmorsy, Ghada F. Soliman, Laila A. Rashed, Hamed Elgendy
Korean J Anesthesiol. 2019;72(2):169-177. Published online 2018 May 30 DOI: https://doi.org/10.4097/kja.d.18.00005
|
|
Citations to this article as recorded by
 Inhibition of the ERK1/2 Phosphorylation by Dextromethorphan Protects against Core Autistic Symptoms in VPA Induced Autistic Rats: In Silico and in Vivo Drug Repurposition Study
Rubal Singla, Abhishek Mishra, Rupa Joshi, Rohit Kumar, Phulen Sarma, Amit Raj Sharma, Gurjeet Kaur, Alka Bhatia, Bikash Medhi
ACS Chemical Neuroscience.2021; 12(10): 1749. CrossRef Recent Advances in the Clinical Value and Potential of Dexmedetomidine
Xiaotian Liu, Yueqin Li, Li Kang, Qian Wang
Journal of Inflammation Research.2021; Volume 14: 7507. CrossRef Vitamin D3 favorable outcome on recognition memory and prefrontal cortex expression of choline acetyltransferase and acetylcholinesterase in experimental model of chronic high-fat feeding
Zienab Alrefaie, Injy Moustafa
International Journal of Neuroscience.2020; 130(3): 262. CrossRef Sedation Strategies for Procedures Outside the Operating Room
Youn Yi Jo, Hyun Jeong Kwak
Yonsei Medical Journal.2019; 60(6): 491. CrossRef
|